Seòmar agus comataidhean

The National Partnership for Culture met on:

24 June 2020

23 July 2020

4 September 2020

4 November 2020

12 March 2021

29 April 2021

1 July 2021

10 September 2021.

The date of the next meeting has not yet been identified.

The Scottish Government continues to engage with the culture and heritage sectors to build fairer and more inclusive workplaces. Culture and Fair Work is an initial priority theme for the National Partnership for Culture (NPC), with the partnership currently reflecting on the material gathered at the Culture and Fair Work workshop, held on the 29th April. The NPC will use the outputs from the workshop to form recommendations to Ministers, by the end of 2021, on what priority actions should be taken to tackle the key issues faced by the culture sector in Scotland.

Through its flagship Fair Work First policy, the Scottish Government is extending Fair Work criteria to public sector grants, other funding streams and contracts wherever relevant and appropriate to do so. Creative Scotland are also drafting a statement of their commitment to Fair Work principles as an employer and a funder – this will be agreed by unions and published on their website.

Officials meet with the STUC and affiliate unions representatives of the cultural sector regularly to discuss key issues impacting workers in the culture sector, including issues around Fair Work.

The Scottish Government has also delivered on 100-day manifesto commitments to establish a Living Hours accreditation scheme and to expand Fair Work First criteria to support flexible working and oppose fire and rehire practice which will also benefit those working in the culture and heritage sector.

The projected cost of the overall campaign is £800,000 which is being funded by the Scottish Government‘s ‘Reducing Drug Deaths’ budget. We are working in partnership with Scottish Drugs Forum to deliver the campaign which will run until mid-November 2021.

In addition to widening awareness of naloxone, one of the main objectives of the campaign is to ensure that the general public know that overdose deaths are preventable and to address stigmatising attitudes regarding the lives of people who use drugs. Stigmatising attitudes impact on people’s sense of self-worth and therefore the likelihood that people engage with treatment which is an evidenced protective factor against overdose deaths.

The campaign is national and every area in Scotland will have an access to multiple elements of the campaign resource. However, it was crucial that lower socio-economic areas, areas with high rates of drug deaths, were identified and particular parts of the campaign, such as bill-board or bus-stop adverts, were closely located to community pharmacies where naloxone would be available.

Creative Scotland has commissioned a review of fair work, leadership, workforce and skills development across the arts, screen and creative industries in Scotland. The review will take place between August 2021 and February 2022.

We announced the launch of the new Just Transition Commission and confirmed Professor Jim Skea as returning Chair on 15 September. Further announcements on the wider membership will be made in due course.

Our response to the previous Just Transition Commission’s report was published alongside Programme for Government and set out our ambitious agenda to achieve a fairer, greener future for all. We are determined to get this right for the people of Scotland, bringing all affected communities with us while learning from unjust transitions in our recent history.

The previous Commission called on the Scottish Government to pursue an orderly, managed transition through the creation of Just Transition Plans for high-emitting industries. In our response, we set out our approach to just transition planning across the Scottish economy and I want the new Commission to play a crucial role in this.

Our new Commission will be delivery focused. It will support (and scrutinise) the production and delivery of Scottish Government-led transition plans.

Specifically, the Commission will be tasked with:

• Providing scrutiny and advice on the ongoing development of Scotland’s Just Transition Plans, including the application of the planning framework, as they are developed;
• Advising on the most suitable approaches to monitoring and evaluation;
• Supporting the Scottish Government’s ambition to be a leader in the international community and to take decisions informed by international best practice;
• Meaningful engagement with those most likely to be impacted by the transition; hearing from a broad range of representative voices to help shape just transition planning in Scotland;
• Publishing an annual report to reflect on Scotland’s progress.

Scotland is the second country in the world, after New Zealand, with 100 per cent Fracture Liaison Service provision across all 14 Health Boards.

Our NHS Recovery Plan, published on 25 August, outlines that the Centre for Sustainable Delivery will work collaboratively with Health Boards, health and social care partners, third sector, academia and industry to identify and implement improvements to care pathways across Scotland. This will include extending new approaches to delivering care that minimise the requirement for patients to travel, and provide services more efficiently – for example virtual appointments and virtual fracture clinics.

1,020 applications were received under the Seafood Producers Resilience Fund. 911 applications were approved and paid a total of £5,808,112 with 109 applications declined.

The Scottish Government Chief Scientist Office (CSO) investment in NHS Research Scotland (NRS) clinical research infrastructure is supporting NHS Health Board participation in a number of COVID-19 vaccine trials to provide data for regulatory submissions for approval for use.

The CSO, NRS and health boards work closely with the UK Vaccines Taskforce to bring a range of vaccine trials to Scotland.

Regulatory approval and licensing conditions for the use of COVID-19 vaccines is a statutory responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

More information about the trials being supported by NHS Research Scotland is available at: COVID-19 vaccine studies | NHS Research Scotland | NHS Research Scotland .

We are working across the Common Travel Area to ensure that the vaccination certification scheme recognises people who were vaccinated in other countries in the Common Travel Area with a Medicines & Healthcare products Regulatory Agency (MHRA) approved vaccine. We will put in place, before the scheme goes live, an interim process to enable Scottish residents who have had a dose outside Scotland to have their vaccine record updated. People will be able to get a record of their vaccination from whichever country they were vaccinated in – this will be accepted in Scotland for entry purposes.

Consultation on this matter took place prior to the announcement by the First Minister, and in line with the provisions of the cooperation agreement.